Mirum Pharmaceuticals (MIRM) Shares Outstanding (Diluted Average) (2021 - 2026)

Mirum Pharmaceuticals has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $58.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 20.38% year-over-year to $58.9 million; the trailing twelve-month figure through Mar 2026 stood at $58.9 million (up 20.38% YoY), and the FY2025 full-year result was $50.2 million, up 5.63% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $58.9 million, up from $50.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $58.9 million in Q1 2026, with the low at $31.3 million in Q1 2022.
• Average Shares Outstanding (Diluted Average) over 5 years is $43.5 million, with a median of $46.9 million recorded in 2024.
• Year-over-year, Shares Outstanding (Diluted Average) rose 24.56% in 2024 and advanced 4.18% in 2025.
• Tracing MIRM's Shares Outstanding (Diluted Average) over 5 years: stood at $34.0 million in 2022, then increased by 20.31% to $40.9 million in 2023, then grew by 16.23% to $47.5 million in 2024, then grew by 5.63% to $50.2 million in 2025, then grew by 17.24% to $58.9 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $58.9 million (Q1 2026), $50.2 million (Q4 2025), and $57.0 million (Q3 2025), per Business Quant data.

Peer Comparison